AstraZeneca R&D employs over 11,000 people at research facilities in the UK, the US, Sweden, France, Canada, India, China and Japan, complemented by a worldwide clinical development capability.
Main R&D facilities
Small molecule research sites:
UK : Alderley Park, Macclesfield, Charnwood and London (Arrow Therapeutics)
Sweden : Lund, Mölndal and Södertälje
US : Boston MA and Wilmington DE
Canada : Montreal QC
France : Reims
India : Bangalore
China : Shanghai
Japan : Osaka (Clinical development)
MedImmune biologics and vaccines research sites:
US : Gaithersburg MD and Mountain View CA
UK : Cambridge
-
Innovation Center China (ICC)
